Evidence map›Paper›PMID 31828002›Full record

ArticleCurrent epidemiology reports2019

The metabolome: A key measure for exposome research in epidemiology.

Douglas I Walker, Damaskini Valvi, Nathaniel Rothman, Qing Lan, Gary W Miller, Dean P Jones

Registry-linked trialAbstract read
In one paragraph

Article in Current epidemiology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05780047 (Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals), which is not on this map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05780047 nacompletednot on this mapstarted 2022, after this paper: background citation

Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals (EDCs) in Women of Child-Bearing Age and Their Partners

TypeinterventionalSponsorMillion Marker Wellness, Inc.Ran2022 to 2022Enrolled434ConditionsEndocrine Disrupting Chemicals, Environmental Exposure, Health Literacy, Bisphenol AArmsMail-in Urine Test for EDCs
3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Trial
  2. Review
  3. Association of age-related macular degeneration with exposome related metabolomics.Metabolomics : Official journal of the Metabolomic Society · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Metabolomics: a new frontier in neurodegenerative disease biomarker discovery.Metabolomics : Official journal of the Metabolomic Society · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Douglas I WalkerDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY.
Damaskini ValviDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston MA, United States.
Nathaniel RothmanCancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Qing LanCancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Gary W MillerDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York NY.
Dean P JonesClinical Biomarkers Laboratory, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, Atlanta, GA.

Funding

Untargeted Analysis ResourceU2CES026561 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WRIGHT, ROBERT O · 2015 to 2025
$24.5M
Pilot Project ProgramP30ES019776 · NIEHS · EMORY UNIVERSITY · PI William Michael Caudle · 2013 to 2026
$22.6M
The Mount Sinai Transdisciplinary Center on Early Environmental ExposuresP30ES023515 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Manish Arora · 2014 to 2026
$21.3M
U2C Experimental CoreU2CES030163 · NIEHS · EMORY UNIVERSITY · PI JONES, DEAN PAUL, LI, SHUZHAO · 2018 to 2021
$3.6M
An environment-wide association study in autism spectrum disorders using novel bioinformatics methods and metabolomics via mass spectrometryR01MH107205 · NIMH · BOSTON CHILDREN'S HOSPITAL · PI KONG, SEK WON · 2015 to 2019
$2.1M
Orbitrap Elite/H-ESI BundleS10OD018006 · OD · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 2014 to 2014
$600k
The adipose exposome effects on the plasma metabolome, body composition and metabolic outcomes after bariatric surgeryR21ES028903 · NIEHS · EMORY UNIVERSITY · PI CHATZI, VAIA LIDA, ZIEGLER, THOMAS R · 2018 to 2019
$455k
Developmental Exposure to Perfluoroalkyl Substances and Cardiometabolic Outcomes in Adulthood: Potential Links via the Plasma MetabolomeR21ES029328 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI VALVI, DAMASKINI · 2019 to 2020
$425k
NIEHS NIH HHS P30 ES019776NIEHS NIH HHS P30 ES023515NIEHS NIH HHS R21 ES028903NIEHS NIH HHS R21 ES029328NIEHS NIH HHS U2C ES026561NIEHS NIH HHS U2C ES030163NIH HHS S10 OD018006NIMH NIH HHS R01 MH107205
6 · The paper itself

Abstract

purpose of reviewApplication of omics to study human health has created a new era of opportunities for epidemiology research. However, approaches to characterize exogenous health triggers have largely not leveraged advances in analytical platforms and big data. In this review, we highlight the exposome, which is defined as the cumulative measure of exposure and biological responses across a lifetime as a cornerstone for new epidemiology approaches to study complex and preventable human diseases. RECENT

findingsWhile no universal approach exists to measure the entirety of the exposome, use of high-resolution mass spectrometry methods provide distinct advantages over traditional biomonitoring and have provided key advances necessary for exposome research. Application to different study designs and recommendations for combining exposome data with novel data analytic frameworks to study complex interactions of multiple stressors are also discussed. SUMMARY: Even though challenges still need to be addressed, advances in methods to characterize the exposome provide exciting new opportunities for epidemiology to support fundamental discoveries to improve public health.

Indexed as

Environmental epidemiologyExposomeHigh-resolution exposomicsHigh-resolution metabolomicsMetabolome-wide association studyPrecision medicine

Identifiers

PMID31828002
PMCPMC6905435

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.